TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
MittVaccin Sverige AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
35,612
|
23,071
|
27,237 |
Financial expenses |
303
|
218
|
161 |
Earnings before taxes |
10,098
|
2,198
|
2,251 |
EBITDA |
12,497
|
4,376
|
4,369 |
Total assets |
40,152
|
27,109
|
14,575 |
Current assets |
39,949
|
24,960
|
10,337 |
Current liabilities |
15,474
|
13,893
|
3,622 |
Equity capital |
3,884
|
3,937
|
3,681 |
- share capital |
892
|
833
|
859 |
Employees (average) |
7
![]() |
7
|
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
9.7%
|
14.5%
|
25.3% |
Turnover per employee |
5,087
|
3,296
|
5,447 |
Profit as a percentage of turnover |
28.4%
|
9.5%
|
8.3% |
Return on assets (ROA) |
25.9%
|
8.9%
|
16.5% |
Current ratio |
258.2%
|
179.7%
|
285.4% |
Return on equity (ROE) |
260.0%
|
55.8%
|
61.2% |
Change turnover |
10,904
|
-3,348
|
22,579 |
Change turnover % |
44%
|
-13%
|
485% |
Chg. No. of employees |
0
|
2
![]() |
2 |
Chg. No. of employees % |
0%
|
40%
|
67% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.